Metoprolol does help with certain types of arrhythmia, particularly those driven by a fast or irregular heart rate. It’s one of the most commonly prescribed beta-blockers for rhythm problems, and it works by slowing the heart’s electrical signals. That said, how well it works depends heavily on the type of arrhythmia you have.
How Metoprolol Affects Heart Rhythm
Your heart’s rhythm is controlled by electrical signals that travel through specialized tissue. In many arrhythmias, those signals fire too quickly or travel through the heart in a disorganized way. Metoprolol blocks beta-1 receptors, which are proteins on heart cells that respond to adrenaline and similar stress hormones. When those receptors are blocked, two things happen: the heart’s natural pacemaker generates signals more slowly, and the electrical “gate” between the upper and lower chambers (the AV node) conducts those signals at a reduced pace.
The practical result is a slower, more controlled heart rate. This makes metoprolol especially useful for arrhythmias where the core problem is speed or overexcitation rather than a structural defect in the heart’s wiring.
Atrial Fibrillation and Rate Control
Atrial fibrillation (AFib) is the most common arrhythmia metoprolol is prescribed for. In AFib, the upper chambers of the heart quiver chaotically instead of contracting in a coordinated way, which can push the heart rate well above 100 beats per minute. Metoprolol doesn’t fix the chaotic rhythm itself. Instead, it controls how fast those disorganized signals pass through to the lower chambers, bringing the overall heart rate down to a safer range.
In clinical comparisons, intravenous metoprolol achieved rate control in about 35% of AFib patients in an acute setting, which was statistically similar to diltiazem (a calcium channel blocker often used for the same purpose) at 41%. Those numbers reflect the more challenging scenario of bringing a rapid heart rate under control quickly in a hospital. For long-term management with oral doses, metoprolol is a standard first-line option and tends to work more consistently as levels stabilize over days.
Premature Ventricular Contractions (PVCs)
PVCs are extra heartbeats that originate in the lower chambers and feel like a skipped beat or a flutter in the chest. They’re extremely common and usually harmless, but when they happen frequently, they can be uncomfortable and occasionally affect heart function over time.
Metoprolol is often the first medication tried for bothersome PVCs, though its effect is modest. In a randomized crossover trial in pediatric patients, metoprolol reduced PVC burden by an average of 2.4 percentage points. By comparison, flecainide (a dedicated anti-arrhythmic drug) reduced it by 10.6 percentage points in the same study. So metoprolol can take the edge off frequent PVCs, but for people with a high PVC burden, a more targeted medication may be needed.
Ventricular Tachycardia Prevention
Ventricular tachycardia (VT) is a more serious arrhythmia where the lower chambers beat dangerously fast. People who’ve had episodes of VT or ventricular fibrillation often have an implantable defibrillator (ICD) placed and are also put on medication to reduce how often their device needs to fire.
In a study of 100 patients with ICDs, metoprolol and sotalol (another beta-blocker with additional anti-arrhythmic properties) were compared head to head. About a third of patients on each drug had at least one recurrent episode during follow-up, and survival curves showed no significant difference between the two. The takeaway is that metoprolol performs comparably to sotalol for preventing VT recurrences, making it a reasonable choice for people who need long-term suppression of dangerous rhythms alongside a defibrillator.
How Quickly It Works
Oral metoprolol starts lowering heart rate within about 2 hours of your first dose. However, the full therapeutic effect, where your heart rate and rhythm are consistently controlled throughout the day, can take up to a week to develop. This is partly because doctors typically start at a low dose and increase it gradually, and partly because the body needs time to adjust to the medication’s effects.
Metoprolol comes in two forms. The immediate-release version (tartrate) has a short half-life of 3 to 4 hours and is usually taken two or three times a day. The extended-release version (succinate) is designed for once-daily dosing, which most people find easier to manage long-term. For arrhythmia control, the extended-release form offers more stable blood levels throughout the day, reducing the chance of breakthrough episodes between doses.
Common Side Effects
Because metoprolol slows the heart and lowers blood pressure, the most frequent side effects are directly related to those actions. Tiredness and dizziness are the ones people notice most. Other reported effects include depression, shortness of breath during exertion, diarrhea, and reduced exercise tolerance. These are generally mild and often improve over the first few weeks as your body adjusts.
Bradycardia, where the heart rate drops too low, is the side effect most relevant to arrhythmia patients. If you already have a tendency toward a slow heart rate, metoprolol can push it further. Low blood pressure can also occur, particularly when standing up quickly. For people with diabetes, metoprolol can mask the typical warning signs of low blood sugar, like a racing heart and shakiness, so blood glucose monitoring becomes more important.
Who Should Not Take It
Metoprolol is not safe for everyone with an arrhythmia. It’s contraindicated if your resting heart rate is already below 45 beats per minute, if you have second- or third-degree heart block without a pacemaker, or if you have significant first-degree heart block (defined by a specific slowing on an ECG). People in cardiogenic shock or with decompensated heart failure also cannot take it.
These restrictions exist because metoprolol slows conduction through the heart. In someone whose conduction system is already compromised, that additional slowing could cause the heart to beat dangerously slowly or stop conducting signals between chambers altogether. If you have one of these conditions but still need rate control, your doctor will choose a different approach or ensure a pacemaker is in place first.
Where Metoprolol Fits Among Treatments
Metoprolol is a rate-control drug, not a rhythm-control drug. This distinction matters. Rate control means keeping the heart from beating too fast during an arrhythmia. Rhythm control means trying to restore and maintain a normal rhythm altogether. For conditions like AFib, doctors often start with rate control using metoprolol or a similar beta-blocker, then decide later whether rhythm control with a different class of medication or a procedure like ablation is warranted.
For PVCs and certain ventricular arrhythmias, metoprolol serves as a first-line option because it’s well-tolerated and carries fewer risks than dedicated anti-arrhythmic drugs, which can sometimes worsen rhythm problems. When metoprolol alone isn’t enough, it’s often kept as a foundation while a second medication is added on top.